ICU Medical, Incorporated (NASDAQ:ICUI) Director Robert S. Swinney sold 229 shares of the firm’s stock in a transaction on Friday, April 12th. The stock was sold at an average price of $231.43, for a total value of $52,997.47. Following the completion of the transaction, the director now owns 18,076 shares in the company, valued at approximately $4,183,328.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of NASDAQ ICUI opened at $234.55 on Wednesday. ICU Medical, Incorporated has a 52 week low of $210.94 and a 52 week high of $321.70. The firm has a market capitalization of $4.83 billion, a P/E ratio of 30.42 and a beta of 0.74.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings results on Thursday, February 28th. The medical instruments supplier reported $1.78 EPS for the quarter, topping the Zacks’ consensus estimate of $1.56 by $0.22. ICU Medical had a return on equity of 13.31% and a net margin of 2.06%. The company had revenue of $340.38 million for the quarter, compared to analysts’ expectations of $314.60 million. On average, analysts expect that ICU Medical, Incorporated will post 8.58 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently modified their holdings of the stock. AQR Capital Management LLC grew its position in ICU Medical by 566.3% in the third quarter. AQR Capital Management LLC now owns 382,179 shares of the medical instruments supplier’s stock valued at $108,061,000 after acquiring an additional 324,819 shares during the last quarter. FMR LLC grew its position in ICU Medical by 91.1% in the fourth quarter. FMR LLC now owns 417,787 shares of the medical instruments supplier’s stock valued at $95,937,000 after acquiring an additional 199,185 shares during the last quarter. Norges Bank bought a new position in ICU Medical in the fourth quarter valued at about $41,575,000. Partner Fund Management L.P. bought a new position in ICU Medical in the fourth quarter valued at about $40,359,000. Finally, American Century Companies Inc. grew its position in ICU Medical by 175.6% in the fourth quarter. American Century Companies Inc. now owns 252,304 shares of the medical instruments supplier’s stock valued at $57,937,000 after acquiring an additional 160,768 shares during the last quarter. Institutional investors own 92.78% of the company’s stock.
ICUI has been the topic of a number of recent analyst reports. BidaskClub upgraded ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, January 2nd. Zacks Investment Research cut ICU Medical from a “hold” rating to a “sell” rating in a research report on Friday, January 4th. Raymond James decreased their price target on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating on the stock in a research report on Friday, March 1st. Finally, TheStreet cut ICU Medical from a “b-” rating to a “c+” rating in a research report on Tuesday, March 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $281.00.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.